MMED
MiniMed Group, Inc. Common Stock
There isn't enough reported data to score MMED yet.
MMED Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Strong |
MMED's balance sheet is currently strong, but its profitability is under pressure. There isn't enough data to rate its revenue and cash flow.
MMED PE Valuation
MMED has no meaningful PE right now: it lost money over the past year.
MMED Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MMED, with profitability improving.
MMED Earnings Per Share
MMED Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $843M | +17% |
| Q2 2026 | $837M | +16% |
| Q1 2026 | $790M | +15% |
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.6% | +0.2 points |
| Q2 2026 | -11% | +17 points |
| Q1 2026 | -13% | -16 points |
| Q4 2025 | -1.3% | N/A |
| Q3 2025 | 0.4% | N/A |
| Q2 2025 | -28% | N/A |
| Q1 2025 | 3.2% | N/A |
MMED's operating margin was 0.6% last quarter, about level with the same quarter a year ago.
MMED Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$90M | +$104M |
| Q2 2026 | -$226M | -969% |
MMED Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.5% | +24.4M shares |
| 1 year | +0.1% | +187K shares |
MMED has 281M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
MMED Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -2.7x | Net Cash |
MMED has more cash than debt.
MMED Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.7 | Neutral |
| Stochastic | 13.5 | Oversold |
MMED's weekly RSI is 41 (neutral) and its Stochastic is 14 (oversold).
MMED PE vs Healthcare Sector
MMED has no meaningful PE right now: it lost money over the past year.
MMED Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.5 | 3.4% below |
| 20 week MA | $18.9 | 5.5% below |
MMED is in a downtrend: it's below all two of its weekly moving averages, and 5.5% below its 20-week average.
MMED Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $18.5 | $17.9 | -3.3% |
It's down 3.3% so far in 2026.